Phase I dosage finding and pharmacokinetic study of intravenous topotecan and oral erlotinib in adults with refractory solid tumors

Biomarkers of Clinical Responsiveness in Brain Tumor Patients

(2012) Areej El-Jawahri et al.   Molecular Diagnosis & Therapy

Phase II trial of lapatinib and topotecan (LapTop) in patients with platinum-refractory/resistant ovarian and primary peritoneal carcinoma

(2011) S. John Weroha et al.   GYNECOLOGIC ONCOLOGY

Tyrosine Kinase Inhibitor Gefitinib Enhances Topotecan Penetration of Gliomas

(2010) Angel M. Carcaboso et al.   CANCER RESEARCH

Non-small-cell lung cancer harbouring mutations in the EGFR kinase domain

(2010) Rafael Rosell et al.   Clinical & Translational Oncology

Colorectal cancer in review: the role of the EGFR pathway

(2010) Muhammad W Saif   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Compartment-Specific Roles of ATP-Binding Cassette Transporters Define Differential Topotecan Distribution in Brain Parenchyma and Cerebrospinal Fluid

(2009) J. Shen et al.   CANCER RESEARCH

Efficacy and safety of erlotinib in patients with locally advanced or metastatic breast cancer

(2008) Maura N. Dickler et al.   BREAST CANCER RESEARCH AND TREATMENT

EGFR/HER2 in breast cancer: a biological approach for molecular diagnosis and therapy

(2008) Fernanda Milanezi et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

Dysregulated molecular networks in head and neck carcinogenesis

(2008) Alfredo A. Molinolo et al.   ORAL ONCOLOGY